{"id":"NCT00844805","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)","officialTitle":"Infliximab as First Line Therapy in Patients With Early Active Axial Spondyloarthritis Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2011-04","completion":"2011-09","firstPosted":"2009-02-16","resultsPosted":"2012-12-17","lastUpdate":"2017-04-12"},"enrollment":158,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondylitis","Axial Spondyloarthritis"],"interventions":[{"type":"DRUG","name":"Infliximab","otherNames":["Remicade","SCH 215596"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Naproxen","otherNames":["Naprosyn"]}],"arms":[{"label":"Infliximab + Naproxen","type":"EXPERIMENTAL"},{"label":"Placebo + Naproxen","type":"PLACEBO_COMPARATOR"},{"label":"Naproxen Only (Follow-Up)","type":"EXPERIMENTAL"},{"label":"No Treatment (Follow-Up)","type":"NO_INTERVENTION"}],"summary":"The primary objective of this study was to assess the proportion of participants in the infliximab plus naproxen arm versus the placebo plus naproxen arm, in a population of participants with moderate-to-severe active axial spondyloarthritis and disease duration of â‰¤3 years, who achieve the Assessment in Ankylosing Spondylitis (ASAS) partial remission criteria.","primaryOutcome":{"measure":"Number of Participants Achieving the Assessment in Ankylosing Spondylitis (ASAS) Partial Remission Criteria at Week 28","timeFrame":"Week 28","effectByArm":[{"arm":"Infliximab + Naproxen","deltaMin":65,"sd":null},{"arm":"Placebo + Naproxen","deltaMin":18,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["23696633","23740231","27015283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":105},"commonTop":["Nasopharyngitis","Abdominal Pain Upper","Headache","Dyspepsia","Rhinitis"]}}